Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

for
Major Depressive Disorder (MDD)
Location: Toronto, Whitby, Hamilton, Kingston, Halifax, Calgary,
Sponsor: Abraham Nunes

Sex: All

Age: 18 - 70

Code: NCT06746155

Recruiting
Active & Responsive

Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

for
Long COVID, Post Acute Sequelae of COVID-19,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06452095

Recruiting
Active & Responsive

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

for
Major Depressive Disorder
Location: Toronto, Whitby, Hamilton, Kingston, Ottawa, Halifax,
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 18 - 65

Code: NCT05017311

Recruiting
Active & Responsive

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

for
Osteoarthritis of Knee, Osteoarthritis Hip
Location: Toronto, Montreal
Sponsor: University Health Network, Toronto

Sex: All

Age: 40 - 70+

Code: NCT06878417

Recruiting
Active & Responsive

An Innovative Master Platform for Clinical Trials in Mood Disorders

for
Mood Disorders, Depressive Disorder,
Location: Toronto, Whitby, Hamilton, Kingston, Ottawa, Halifax,
Sponsor: St. Joseph's Healthcare Hamilton

Sex: All

Age: 16+

Code: NCT06408012

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Theta-Burst Stimulation for Bipolar Depression

for
Bipolar Depression, Bipolar Disorder,
Location: Toronto
Sponsor: Centre for Addiction and Mental Health

Sex: All

Age: 18 - 65

Code: NCT06370988

Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: Toronto, Cleveland OH, Ann Arbor MI, Columbus OH,
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting
Active & Responsive

Characterizing Synaptic Density in Treatment Resistant Depression

for
Treatment Resistant Depression,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 25 - 65

Code: NCT03537794

Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Toronto, London, Mentor OH, Montreal, New York NY,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase 2, Recruiting
Active & Responsive

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

for
Chronic Kidney Disease
Location: Toronto, Waterloo, Minneapolis MN, Arlington TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07753993

Phase 3, Recruiting
Active & Responsive

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

for
Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA),
Location: Toronto
Sponsor: AstraZeneca

Sex: All

Age: 6+

Code: NCT07444567

Phase 3, Recruiting
Active & Responsive

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

for
Type 2 Diabetes Mellitus
Location: Toronto, Ocoee FL, Vancouver
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07664553

Phase 3, Recruiting
Active & Responsive

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: Toronto, Montreal, New York NY, New Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase 3, Recruiting
Active & Responsive

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

for
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV,
Location: Toronto, Montreal, Halifax, Calgary
Sponsor: AstraZeneca

Sex: All

Age: 18

Code: NCT07509151

Phase 3, Recruiting
Active & Responsive

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Toronto, Concord, Etobicoke, Pittsburgh PA, Flint MI,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase 2, Recruiting
Active & Responsive

RA-PRO PRAGMATIC TRIAL

for
Rheumatoid Arthritis
Location: Toronto, Cleveland OH, Pittsburgh PA, Duncansville PA,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04692493

Phase 3, Recruiting
Active & Responsive

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

for
Scleroderma, Systemic, Digital Ulcer
Location: Toronto, London, Ottawa, Calgary
Sponsor: Primus Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06256575

Recruiting
Active & Responsive

Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation

for
Twin; Pregnancy, Affecting Fetus or Newborn,
Location: Toronto, Boston MA
Sponsor: Leiden University Medical Center

Sex: All

Age: 18 - 50

Code: NCT05952583

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Toronto, Vaughan, Buffalo NY, Rochester NY, Westlake OH,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Toronto, Detroit MI, Montreal, Nyack NY, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase 3, Recruiting